Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04369378 · ClinicalTrials.gov registry record · NA
Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic
A NA study, sponsored by Lake Erie College of Osteopathic Medicine.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT04369378: Completed NA study, sponsored by Lake Erie College of Osteopathic Medicine.
NCT04369378 is a NA study that has completed, run by Lake Erie College of Osteopathic Medicine. The registered enrollment target is 103 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04369378, a NA study, has completed, sponsored by Lake Erie College of Osteopathic Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
This interventional study will investigate the effect of daily use of a mindfulness app on measures of participant anxiety, well-being, and future outlook during the Covid-19 pandemic, by comparing pre-intervention survey responses to post-intervention survey responses.
Primary Outcome
Assessed by survey questions (in part adapted from GAD7)
Interventions
- BEHAVIORAL Meditation app usage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2020-08-19 |
| Est. Completion | 2021-08-26 |
| Phase | NA |
What the finished NCT04369378 record still lists
NCT04369378 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Meditation app usage is the first listed.
NCT04369378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04369378 about?
NCT04369378 is a clinical study titled "Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic". This interventional study will investigate the effect of daily use of a mindfulness app on measures of participant anxiety, well-being, and future outlook during the Covid-19 pandemic, by comparing pre-intervention survey responses to post-intervention survey responses.
What is the current status of trial NCT04369378?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2020-08-19. Estimated completion is 2021-08-26.
What interventions are being tested in trial NCT04369378?
The interventions under investigation include: Meditation app usage (BEHAVIORAL).
Who is sponsoring clinical trial NCT04369378?
This trial is sponsored by Lake Erie College of Osteopathic Medicine, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04369378's enrollment target sits among peer trials
103 837th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI